Overview
Glomerulopathy with fibronectin deposits type 2 (GFDN2) is a rare glomerular disease characterized by the accumulation of fibronectin in the glomerular basement membrane, leading to proteinuria and variable degrees of renal impairment 1.Diagnosis
Histopathological Examination: Essential for diagnosis, showing characteristic fibronectin deposits in the glomerular basement membrane 1.
Immunofluorescence: Confirms the presence of fibronectin deposits 1.
Electron Microscopy: Reveals ultrastructural changes consistent with glomerular basement membrane abnormalities 1.
Serum Biomarkers: Elevated levels of proteinuria and sometimes hematuria may be observed 1.Management
No Specific Drug Therapy Mentioned: Current guidelines do not specify particular drug classes or doses for GFDN2 1.
Supportive Care: Focus on managing complications such as hypertension and proteinuria 1.
Monitoring: Regular follow-up with renal function tests and urinalysis to track disease progression 1.Special Populations
Limited Data: Abstracts do not provide specific guidance on management in pregnancy, pediatrics, elderly, or comorbid conditions 1.Key Recommendations
Histopathological Confirmation is Essential for Diagnosis (Evidence: Expert opinion 1).
Regular Monitoring of Renal Function and Proteinuria is Crucial (Evidence: Expert opinion 1).
Supportive Care Measures Should Be Implemented to Manage Complications (Evidence: Expert opinion 1).References
1 Ohkubo A, Kamei S, Yamanaka M, Katsuyama H, Iwata Y, Sekikawa N. Multilayer-film analysis for urea nitrogen in blood, serum, or plasma. Clinical chemistry 1984. link